Thus, our results shed light on a role of the TP53-ΔNP63-EFNB1-EPHB4-EMT/cell cycle axis in oncogenic destruction of epithelial tissues during ESCC progression. The gene discussed is EPHB4; the disease is esophageal squamous cell carcinoma.